Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative FOLFOX vs Postoperative Chemotherapy in Rectal Cancer
NCT04495088Phase 3Terminated
- Start
- Sep 2020
- Primary completion
- Jul 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of mFOLFOX6, Capecitabine + oxaliplatin in rectal cancer. Started Sep 2020; status: terminated.
02
Drugs
mFOLFOX6Capecitabine + oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04495088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04495088.